Preparation and Identification of Polymorphs and Solvatomorphs

Preformulation in Solid Dosage Form Development

Volumn , Issue , 2008, Pages 185-228

  Brittain, Harry G ^a  

^a Center for Pharmaceutical Physics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956356182     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780849360862-11     Document Type: Chapter

References (111)

1. Brittain HG. Polymorphism in Pharmaceutical Solids. New York: Marcel Dekker, 1999.
2. Byrn SR, Pfeiffer RR, Stowell JG. Solid State Chemistry of Drugs, 2nd edn. West Lafayette, IN: SSCI Inc., 1999.
3. WC McCrone. Polymorphism (chap. 8). In: Fox D, Labes MM, Weissberger A, eds. Physics and Chemistry of the Organic Solid State, Vol. II. New York: Interscience Publishers, 1965, pp. 725-67.
4. Haleblian JK, McCrone WC. Pharmaceutical applications of polymorphism. J Pharm Sci 1969; 58:911-29.
5. Haleblian JK. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J Pharm Sci 1975; 64:1269-88.
6. Borka L. Review on crystal polymorphism of substances in the European Pharmacopeia. Pharm Acta Helv 1991; 66:16-22.
7. Byrn SR, Pfeiffer RR, Stephenson G, Grant DJW, Gleason WB. Solid-state pharmaceutical chemistry. Chem Mater 1994; 6:1148-58.
8. Byrn SR, Pfeiffer RR, Ganey M, Hoiberg C, Poochikian G. Pharmaceutical solids: a strategic approach to regulatory considerations. Pharm Res 1995; 12: 945-54.
9. Brittain HG. The impact of polymorphism on drug development: a regulatory viewpoint. Am Pharm Rev 2000; 3:67-70.
10. Vippagunta SR, Brittain HG, Grant DJW. Crystalline solids. Adv Drug Dev Rev 2001; 48:3-26.
11. Brittain HG. Polymorphism: pharmaceutical aspects. In: Swarbrick J, Boylan JC, eds. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker, 2002, pp. 2239-49.
12. Newman AW, Stahly GP. Form selection of pharmaceutical compounds (chap. 1). In: Ohannesian L, Streeter AJ, eds. Handbook of Pharmaceutical Analysis. New York: Marcel Dekker, 2001, pp. 1-57.
13. Threlfall T, Org Proc Res Dev 2000; 4:384-90.
14. Ostwald W. Lehrbuch, Vol. 2. Leipzig: Engelmann Press, 1897.
15. Guillory JK. Generation of polymorphs, hydrates, solvates, and amorphous solids (chap. 5). In: Brittain HG, ed. Polymorphism in Pharmaceutical Solids. New York: Marcel Dekker, 1999, pp. 183-226.
16. Snyder LR. J Chrom Sci 1978; 16:223.
17. Sadek PC. The HPLC Solvent Guide. New York: John Wiley & Sons, 1996.
18. Riddick JA, Bunger WB. Organic Solvents, 3rd edn. New York: Wiley-Interscience, 1970.
19. Mullin JW. Crystallization, 2nd edn. Cleveland, OH: CRC Press, 1972, pp. 52-3.
20. Bonafede SJ, Ward MD. J Am Chem Soc 1995; 117:7853-61.
21. Mitchell CA, Yu L, Ward MD. J Am Chem Soc 2001; 123:10830-9.
22. Gorbitz CH, Hersleth H-P. Acta Cryst B 2000; 56:526-34.
23. Morris KR, Rodriguez-Hornedo N. Encyclopedia of Pharmaceutical Technology, vol. 7. New York: Marcel Dekker, 1993, pp. 393-440.
24. Khankari RK, Grant DJW. Thermochim Acta 1995; 248:61-79.
25. Suryanarayanan R. X-ray powder diffractometry (chap. 7). In: Brittain HG, ed. Physical Characterization of Pharmaceutical Solids. New York: Marcel Dekker, 1995, pp. 187-221.
26. Klug HP, Alexander LE. X-ray diffraction procedures for polycrystalline and amorphous materials, 2nd edn. New York: Wiley-Interscience, 1974.
27. Phadnis NV, Cavatus RK, Suryanarayanan R. J Pharm Biomed Anal. 1997; 15:929-43.
28. Pirttmaki J, Lehto V-P, Laine E. Drug Dev Ind Pharm 1993; 19:2561-77.
29. Bragg WH, Bragg WL. X-Rays and Crystal Structure. London: G. Bell & Sons, 1918.
30. Rousseau JJ. Basic Crystallography. Chichester: John Wiley & Sons, 1998, pp. 188-91.
31. Epple M, Cammenga HK. Ber Bunsenges Phys Chem 1992; 96:1774-8.
32. Conflant P, Guyot-Hermann A-M. Eur J Pharm Biopharm 1994; 40:388-92.
33. Rastogi S, Zakrzewski M, Suryanarayanan R. Pharm Res 2001; 18:267-73; 2002; 18:1265-73.
34. McCrone WC, McCrone LB, Delly JG. Polarized Light Microscopy., Ann Arbor, MI: Ann Arbor Science Publishers, 1978.
35. Rochow TG, Rochow EG. An Introduction to Microscopy by Means of Light, Electrons, X-Rays, or Ultrasound. New York: Plenum Press, 1978.
36. Newman AW, Brittain HG. Particle morphology: optical and electron microscopies (chap. 5). In: HG Brittain, ed. Physical Characterization of Pharmaceutical Solids. Marcel Dekker, New York, 1995, pp. 127-56.
37. McCrone WC. Fusion Methods in Chemical Microscopy. New York: Interscience Publishers, 1957.
38. Kuhnert-Brandstätter M. Thermomicroscopy in the Analysis of Pharmaceuticals. Oxford: Pergamon Press, 1971.
39. Wendlandt WW. Thermal Analysis, 3rd edn. New York: John Wiley & Sons, 1986.
40. Ford JL, Timmins P. Pharmaceutical Thermal Analysis. Chichester: Ellis Horwood Ltd., 1989.
41. McCauley JA, Brittain HG. Thermal methods of analysis (chap. 8). In: HG Brittain, ed. Physical Characterization of Pharmaceutical Solids. New York: Marcel Dekker, 1995, pp. 223-51.
42. Pope MI, Judd MD. Introduction to Differential Thermal Analysis. London: Heyden, 1977.
43. Dollimore D. Thermoanalytical instrumentation. In: Ewing GW, ed. Analytical Instrumentation Handbook. New York: Marcel Dekker, 1990, pp. 905-60.
44. Keattch CJ, Dollimore D. Introduction to Thermogravimetry, 2nd edn. London: Heyden, 1975.
45. Wilson EB, Decius JC, Cross PC. Molecular Vibrations. New York: McGraw Hill, 1955.
46. Ciurczak EW, Drennen JK. Pharmaceutical and Medical Applications of Near-Infrared Spectroscopy. New York: Marcel Dekker, 2002.
47. Bugay DE, Williams AC. Vibrational spectroscopy (chap. 3). In: Brittain HG, ed. Physical Characterization of Pharmaceutical Solids. New York: Marcel Dekker, 1995, pp. 59-91.
48. Brittain HG. J Pharm Sci 1997; 86:405-12.
49. Conley RT. Infrared Spectroscopy. Boston: Allyn and Bacon, 1966.
50. Lewis IR, Edwards HGM. Handbook of Raman Spectroscopy. New York: Marcel Dekker, 2001.
51. Fyfe CA. Solid State NMR for Chemists. Guelph: CFC Press, 1983.
52. Bugay DE. Magnetic resonance spectrometry (chap. 4). In: Brittain HG, ed. Physical Characterization of Pharmaceutical Solids. New York: Marcel Dekker, 1995, pp. 93-125.
53. Bugay DE. Pharm Res 1993; 10:317-27.
54. Yanagi T, Mizoguchi J-I, Adachi T, et al. Chem Pharm Bull 2000; 48:366-9.
55. Giordano F, Rossi A, Moyano JM, et al. J Pharm Sci 2001; 90:1154-63.
56. Kimura N, Fukui H, Takagaki H, Yonemochi E, Terada K. Chem Pharm Bull 2001; 49:1321-5.
57. Kushida I, Ashizawa K. J Pharm Sci 2002; 91:2193-202.
58. Singh D, Marshall PV, Shields L, York P. J Pharm Sci 1998; 87:655-62.
59. Alkhamis KA, Obaidat AA, Nuseirat AF. Pharm Dev Tech 2002; 7:491-503.
60. Zornoza A, de No C, Martin C, Goni MM, Martinez-Oharriz MC, Valaz I. Int J Pharm 1999; 186:199-204.
61. Burger A, Lettenbichler A. Eur J Pharm Biopharm 2000; 49:65-72.
62. Gu C-H, Young V, Grant DJW. J Pharm Sci 2001; 90:1878-90.
63. Canterau RG, Leza MG, Bachiller CM. J Pharm Sci 2002; 91:2240-51.
64. Vrcelj RM, Gallagher HG, Sherwood JN. J Am Chem Soc 2001; 123:2291-5.
65. Rollinger JM, Gstrein EM, Burger A. Eur J Pharm Biopharm 2002; 53:75-86.
66. Wenslow RM, Baum MW, Ball RG, McCauley JA, Varsolona RJ. J Pharm Sci 2000; 89:1271-85.
67. van Hoof P, Lammers R, Puijenbroek R, Schans M, Carlier P, Kellenback E. Int J Pharm 2002; 238:215-28.
68. Stowell GW, Behmne RJ, Denton SM, et al. J Pharm Sci 2002; 91:2481-8.
69. Yang Y, Wenslow RM, McCauley JA, Crocker LS. Int J Pharm 2002; 243: 147-59.
70. Edwards HGM, Lawson E, de Matas M, Shields L, York P. J Chem Soc Perkin Trans 1997; 2:1985-90.
71. Ledwidge MT, Corrigan OI. Int J Pharm 1997; 147:41-9.
72. Leung SS, Padden BE, Munson EJ, Grant DJW. J Pharm Sci 1998; 87:501-7; 1998; 87:508-13.
73. Khankari R, Chen L, Grant DJW. J Pharm Sci 1998; 87:1052-61.
74. Chen LR, Padden BE, Vippagunta SR, Munson EJ, Grant DJW. Pharm Res 1999; 17:619-24.
75. Richards AC, McColm IJ, Harness JB. J Pharm Sci 1999; 88:780-5.
76. Richards AC, Harness JB, McColm IJ. J Pharm Sci 2000; 89:1187-95.
77. Richards AC, McColm IJ, Harness JB. J Pharm Sci 2002; 91:1101-16.
78. Zhu H, Khankari RK, Padden BE, Munson EJ, Gleason WB, Grant DJW. J Pharm Sci 1996; 85:1026-34.
79. Zhu H, Halfen JA, Young VG, et al. J Pharm Sci 1997; 86:1439-47.
80. Zhu H, Padden BE, Munson EJ, Grant DJW. J Pharm Sci 1996; 86:418-29.
81. Zhu H, Young VG, Grant DJW. Int J Pharm 2002; 232:23-33.
82. Grant DJW, Higuchi T. Solubility Behavior of Organic Compounds., New York: John Wiley & Sons, 1990.
83. Mader WJ, Vold RD, Vold MJ. In: Weissberger A, ed. Physical Methods of Organic Chemistry, 3rd edn. Vol. 1, part I. New York: Interscience Publishers, 1959, pp. 655-88.
84. Yalkowsky SH, Banerjee S. Aqueous Solubility Methods of Estimation for Organic Compounds. New York: Marcel Dekker, 1992, pp. 149-54.
85. Grant DJW, Brittain HG. Solubility of pharmaceutical solids (chap. 11). In: Brittain HG, ed. Physical Characterization of Pharmaceutical Solids. New York: Marcel Dekker, 1995, pp. 321-86.
86. Brittain HG, Grant DJW. Effects of polymorphism and solid-state solvation on solubility and dissolution rate (chap. 7). In: Brittain HG, ed. Polymorphism in Pharmaceutical Solids. New York: Marcel Dekker, 1999, pp. 279-330.
87. Grant DJW, Mehdizadeh M, Chow AH-L, Fairbrother JE. Int J Pharm 1984; 18:25.
88. Behme RJ, Brooke D, Farney RF, Kensler TT. J Pharm Sci 1985; 74:1041.
89. Sudo S, Sato K, Harano Y. J Chem Eng Japan 1991; 24:237.
90. Jozwiakowski MJ, Williams SO, Hathaway RD. Int J Pharm 1993; 91:195.
91. Milosovich G. J Pharm Sci 1964; 53:781.
92. Laine E, Tuominen V, Ilvessalo P, Kahela P. Int J Pharm 1984; 20:307.
93. Young WWL, Suryanarayanan R. J Pharm Sci 1991; 80:496.
94. Kahela P, Aaltonen R, Lewing E, Anttila M, Kristoffersson E. Int J Pharm 1983; 14:103.
95. Zhu H, Grant DJW. Int J Pharm 1996; 139:33.
96. United States Pharmacopoeia 26. United States Pharmacopoeial Convention, Inc., Rockville MD, 2003, pp. 2155-6.
97. Higuchi WI, Lau PK, Higuchi T, Shell JW. J Pharm Sci 1963; 52:150.
98. Poole JW, Bahal CK. J Pharm Sci 1968; 57:1945.
99. Shefter E, Higuchi T. J Pharm Sci 1963; 52:781.
100. Stagner WC, Guillory JK. J Pharm Sci 1979; 68:1005.
101. Yalkowsky SH. Techniques of Solubilization of Drugs. New York: Marcel Dekker, 1981, pp. 160-80.
102. Fokkens JG, van Amelsfoort JGM, de Blaey CJ, de Kruif CC, Wilting J. Int J Pharm 1983; 14:79.
103. de Smidt JH, Fokkens JG, Grijseels H, Crommelin DJA. J Pharm Sci 1986; 75:497.
104. Zhu H, Yuen C, Grant DJW. Int J Pharm 1996; 135:151.
105. Hoelgaard A, Moller N. Int J Pharm 1983; 15:213.
106. Stoltz M, Caira MR, Ltter AP, van der Watt JG. J Pharm Sci 1989; 78:758.
107. Botha SA, Caira MR, Guillory JK, Ltter AP. J Pharm Sci 1988; 77:444.
108. Levich VG. Physicochemical Hydrodynamics. Englewood Cliffs, NJ: Prentice-Hall, 1962.
109. Laihanen N, Muttonen E, Laaksonen M. Pharm Dev Tech 1996; 1:373.
110. Ibrahim HG, Pisano F, Bruno A. J Pharm Sci 1977; 66:669.
111. Otsuka M, Ofusa T, Matsuda Y. Drug Dev Indust Pharm 1999; 25:197-203.